U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07562789) titled 'Role of PCGEM1 in Breast Cancer' on April 26.
Brief Summary: This study examines certain molecular markers in breast cancer using blood and tissue samples from routine diagnostic biopsies. No extra procedures will be performed on patients. The goal is to improve understanding of disease mechanisms and identify potential targets for treatment
Study Start Date: May 05
Study Type: OBSERVATIONAL
Condition:
Breast Cancer
Intervention:
DEVICE: No Biologics
No intervention will be performed in this study. Tissue samples will be obtained from routine diagnostic biopsies that are already indicated as part of standard clinical care
Recr...